Opinion: Unethical Reporting

Two publications on the same topic are compromised by the decision to separate the data.

Written byDariusz Leszczynski
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Arbitrary data segregation can be at best scientific folly and at worst unethical.
FLICKR, LUKE JONES
The International Commission on Non-Ionizing Radiation Protection (ICNIRP) is currently in process of reviewing scientific evidence concerning whether the radiation emitted by wireless communication devices is harmful. However, some of the evidence published in peer-review journals may have to be discarded due to the flaws. In a recent opinion for The Scientist, I presented flaws of the Danish Cohort, the largest recent epidemiological study to investigate the possible health effects of cell-phone use. The other deeply flawed publications on this topic came out of the Interphone project.

Like the Danish Cohort, the strength of Interphone, an EU-funded epidemiological study to examine the possibility of a causal link between exposures to cell phone radiation and brain cancer, was its large size. In total, 13 countries in the study and researchers examined more than 1,500 cancer cases. But in 2011 Interphone published two studies, neither of which took full advantage of the massive dataset. Instead, each purposefully focused on only part of project’s data.

The first study, published in the American Journal of Epidemiology in May 2011, found no causal link between location of brain areas most exposed to the radio frequency electromagnetic fields (RF-EMF) emitted by cell phone and location of gliomas in people of Denmark, Finland, Germany, Italy, Norway, Sweden, and England. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies